TIB Molbiol
Business Services · Germany · 1-10 Employees
View Company Info for Free
Overview
Headquarters
23 · Eresburgstrasse 22, Berlin, Berlin,...Phone Number
(650) 855-5050Website
www.tib-molbiol.comRevenue
<$5 MillionIndustry
About TIB Molbiol
Is TIB Molbiol your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on TIB Molbiol recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
TIB Molbiol, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if TIB Molbiol had a recent Job posting/layoffs
Product Launch: Get notified when TIB Molbiol launches new products
Check if TIB Molbiol has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once TIB Molbiol has new funding data
Website visits: Recent activity has been detected on your website
Check out if TIB Molbiol is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at TIB Molbiol
Recommended Actions
Reach out to Masked Content who joined TIB Molbiol as Masked Content
Find more new buyers
TIB Molbiol Tech Stack
A closer look at the technologies used by TIB Molbiol
TIB Molbiol News & Media
Roche provides molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants of concern
Basel, 16 March 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and TIB Molbiol, a subsidiary within the Roche Diagnostics division, today announced available testing solutions that can identify the SARS-CoV-2 B.1.1.529 variant and differentiate between the Omicron subvariants BA.1, BA.1.1, BA.2, BA.2.2, BA.3 and Delta.Roche has rapidly developed additional testing options to differentiate mutations in the Omicron SARS-CoV-2 variant
Basel, 3 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and TIB Molbiol, a newly acquired subsidiary within the Roche Diagnostics division, have added three additional Research Use Only (RUO) test kits for the detection of mutations present in the novel B.1.1.529 Omicron SARS-CoV-2 variant: VirSNip SARS Spike ins214EPE (RUO), VirSNiP SARS-CoV-2 Spike S371L S373P (RUO), VirSNip SARS Spike E484A (RUO). The World Health Organization (WHO) has classified the recently emerged SARS-CoV-2 variant,Roche completes purchase agreement with long-term partner TIB Molbiol to expand PCR-test portfolio in the fight against new infectious diseases
Basel, 1 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced it has completed its share purchase agreement to acquire 100 percent of the outstanding shares of TIB Molbiol Group. TIB Molbiol will continue to operate as a subsidiary within the Diagnostics division. Roche and TIB Molbiol will build on their capabilities for the rapid development of assays for emerging pathogens and potential health threats, such as infectious diseases.This German biotech company has developed coronavirus test kits with 4 million tests since the outbreak began
TIB Molbiol Syntheselabor GmbH is a technology company you probably never heard of. Since 1990, Tib Molbiol, a Berlin, Germany-based biotech company that has developed tests for ailments ranging from swine flu to SARS. The company has been providing custom synthesis of […] The post This German biotech company has developed coronavirus test kits with 4 million tests since the outbreak began appeared first on Tech News | Startups News.
Top Business Services Companies
Frequently Asked Questions Regarding TIB Molbiol
TIB MOLBIOL specializes in the custom synthesis of oligonucleotides for life science research, medical diagnostics, and environmental analysis. The company provides high-quality products and support, including COVID-19 PCR test kits and mutation-specific assays. With a global presence, TIB MOLBIOL responds swiftly to critical biological threats. Th... Read More